About inHEART
inHEART is a Healthcare company based in Pessac (France) founded in 2017 by Jean Marc Peyrat, Pierre Jais, and Hubert Cochet. AI-based 3D cardiac models are developed for therapeutic planning. inHEART has raised $15.16 million across 2 funding rounds from investors including NACO, Vesalius Biocapital IV and Elaia. Its chief executive, as recorded, is Todor Jeliaskov. inHEART offers products and services including Digital Twin of the Heart and 3D Imaging Platform. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include eCential Robotics, Biomodex and SurgAR; 3 of its 3 listed competitors have raised funding.
Company details
inHEART was founded in 2017 in Pessac, France, within the medical technology sector focused on cardiology. Software is provided for creating 3D models of cardiac anatomy, supporting educational tools and therapeutic strategies for healthcare providers. Features include segmentation algorithms for tissue details, structural analysis, and integration with electroanatomic mapping systems to aid clinical operations.
- Headquarters Pessac, France
- Founders Jean Marc Peyrat, Pierre Jais, Hubert Cochet
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website inheartmedical.com
- Social LinkedIn X Facebook
- Total Equity Funding$15.16M (USD)
in 2 rounds
- Latest Funding Round$11M (USD), Series B
May 2024
- InvestorsNACO
& 7 more
Products & Services of inHEART
inHEART offers a comprehensive portfolio of products and services, including Digital Twin of the Heart and 3D Imaging Platform.
AI tool for 3D heart modeling from images for ablation procedures.
Platform integrating with mapping systems to enhance cardiac treatments.
Funding Insights of inHEART
inHEART has successfully raised a total of $15.16M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $11 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.16M
- Total Rounds 2
- Last Round Series B — $11M
- First Round $4.16M
(Jul 2020)
- Investors Count 8
All 2 funding rounds of inHEART with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $11M | Series B | – | Vesalius Biocapital, Elaia | |
| Jul 2020 | $4.16M | Series A | – | Elaia, Aquitaine Science Transfert | – |
8 investors in total: 8 institutional.
Investors in inHEART
inHEART has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include NACO, Vesalius Biocapital IV and Elaia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A European life sciences venture capital investor is operated. | vesaliusbiocapital-4.com | Contern, Luxembourg | ||
Venture capital firm focused on early-stage investments | elaia.com | Paris, France | ||
A venture capital fund focused on co-investing in startups. | sofiaventures.eu | Sofia, Bulgaria | ||
Investment opportunities in global high-growth technology startups are facilitated. | webit.network | Sofia, Bulgaria | ||
| cwrfunds.com | ||||
AIDS control initiatives are coordinated through national programs in India. | 1986 | naco.gov.in | Delhi, India | |
Investing in sustainable companies, providing advisory on decarbonization, and talent services globally. | 2017 | sagana.com | Wollerau, Switzerland | |
Delivers comprehensive financial services solutions. | 2012 | ast-innovations.com | Talence, France |
Investor details for inHEART
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of inHEART
31 people are tracked at inHEART (6 in leadership, 16 in board & advisors, 9 in team).
| Name | Role | Group |
|---|---|---|
Jean Marc Peyrat | Co-Founder | Leadership |
Pierre Jais | Co-Founder | Leadership |
Hubert Cochet | Co-Founder | Leadership |
Todor Jeliaskov | CEO | Leadership |
David Gareau, RN | National Director Of Sales & Clinical Development | Leadership |
David Gareau | Director of Sales & Clinical Development | Leadership |
Sacha Loiseau | Board Member | Board & advisors |
Benjamin Bertre | Advisor | Board & advisors |
Allan Zingeler | Board Member | Board & advisors |
Samantha Jerusalmy | Board Member | Board & advisors |
Pierre Jaïs | Clinical Advisor & Founder | Board & advisors |
Maxime Sermesant | Scientific Advisor & Founder | Board & advisors |
Srijoy Mahapatra | Advisor | Board & advisors |
Fred Sacher | Advisor | Board & advisors |
Leo Grady | Scientific Advisor | Board & advisors |
Timm Dickfeld | Clinical Advisor | Board & advisors |
Thomas Deneke | Clinical Advisor | Board & advisors |
Pasquale Santangeli | Clinical Advisor | Board & advisors |
William Stevenson | Clinical Advisor | Board & advisors |
Antoine Bordes | Scientific Advisor | Board & advisors |
11 more people are available in the full profile.
Complete people profiles for inHEART
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of inHEART
3 dated milestones of inHEART across 7 years, from founding to its latest funding, stage changes and deals.
- Founded inHEART is founded.
- Funding First funding round of $4.2M.
- Funding Latest funding round, Series B, of $11.0M.
Competitors of inHEART
inHEART has 3 listed competitors in our database, 3 of them funded. They include eCential Robotics, Biomodex and SurgAR.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ecential-robotics.com | 2009 | Gieres, France | $133.97M | Robotic surgery platform for bone procedures is developed. | ||
| biomodex.com | 2014 | Paris, France | $18.6M | 3D printed surgical simulators for medical education and patient-specific preoperative planning | ||
| surgar-surgery.com | 2019 | Clermont Ferrand, France | $14.39M | Augmented reality software is developed for laparoscopic surgery applications. |
Detailed competitors of inHEART
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of inHEART
The website of inHEART (inheartmedical.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▲ 77.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Inheart
Complete news archive for inHEART
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about inHEART
inHEART was founded in 2017 and raised its 1st funding round 3 years after it was founded.
inHEART is headquartered in Pessac, France. It is registered at Pessac, Gironde, France.
Todor Jeliaskov is the CEO of inHEART, as recorded in our data.
inHEART is a funded company, having raised a total of $15.16M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.16M, raised on Jul 2020.
inHEART was founded in 2017 in Pessac, France, within the medical technology sector focused on cardiology. Software is provided for creating 3D models of cardiac anatomy, supporting educational tools and therapeutic strategies for healthcare providers. Features include segmentation algorithms for tissue details, structural analysis, and integration with electroanatomic mapping systems to aid clinical operations.
inHEART's top competitors include eCential Robotics, SurgAR and Biomodex.
inHEART offers Digital Twin of the Heart and 3D Imaging Platform.
inHEART has 8 investors. Key investors include NACO, Vesalius Biocapital IV, Elaia, SAGANA, and Sofia Angels Ventures.